Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02178943 · ClinicalTrials.gov registry record
Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling
A clinical trial, sponsored by CareDx.
- Completed
- Registry status
- 100
- Enrollment target
NCT02178943 is a clinical trial that has completed, run by CareDx. The registered enrollment target is 100 participants.
The verdict
NCT02178943 has completed, sponsored by CareDx.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Plasma donor-derived cell-free DNA (dd-cfDNA) is measured as a % of the total plasma cfDNA in association with the measurement of AlloMap, a non-invasive gene expression test to aid in heart transplant management.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-06 |
| Est. Completion | 2020-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02178943
The ClinicalTrials.gov registry entry for NCT02178943 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CareDx, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02178943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02178943 about?
NCT02178943 is a clinical study titled "Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling". Plasma donor-derived cell-free DNA (dd-cfDNA) is measured as a % of the total plasma cfDNA in association with the measurement of AlloMap, a non-invasive gene expression test to aid in heart transplant management.
What is the current status of trial NCT02178943?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2014-06. Estimated completion is 2020-02.
Who is sponsoring clinical trial NCT02178943?
This trial is sponsored by CareDx, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.